IMNM
Immunome, Inc.
Stock
$20.90+0.01 (+0.05%)Close Oct 2, 2026
- Operating cash flow, 2025
- −$191M
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | −$191M | — |
| 2024 | −$111M | — |
| 2023 | −$7.6M | — |
| 2022 | −$29M | — |
| 2021 | −$18M | — |
| 2020 | −$12M | — |
| 2019 | −$9.6M | — |